Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / schedule-a-licensed-patents.docx
schedule-a-licensed-patents.docx
Parties
Penterra Pharmaceuticals Corp
Alkerra Manufacturing Inc
Dates
October 2, 2023
October 20, 2023
July 15, 2019
November 3, 2020
May 28, 2021
July 12, 2021
September 3, 2021
January 14, 2022
April 22, 2022
January 25, 2022
Amounts
Obligations
Capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Agreement
To the extent that any PTE, PTA, SPC, or equivalent extension is obtained for any Licensed Patent, the expiration date of such Licensed Patent shall be deemed extended accordingly for all purposes under the Agreement, and this Schedule A shall be updated to reflect such extension in accordance with Section 11
The representations and warranties of Licensor regarding the Licensed Patents, including with respect to validity, enforceability, ownership, and freedom from encumbrances, are set forth exclusively in Article 9 of the Agreement, and nothing in this Schedule A shall be construed to expand or modify such representations and warranties
The Joint Patent Committee ("JPC"), comprised of two (2) representatives designated by Licensor and two (2) representatives designated by Licensee, shall oversee the prosecution, maintenance, defense, and enforcement of the Licensed Patents in the Territory, as more fully set forth in Article 12 of the Agreement
The selection and retention of local counsel and patent agents in each jurisdiction shall be subject to the mutual agreement of the parties through the JPC, as provided in Article 12 of the Agreement
Licensor shall bear all costs and expenses of prosecution and maintenance of the Licensed Patents in the United States; Licensee shall bear all costs and expenses of prosecution and maintenance of the Licensed Patents in the Territory, in each case as more fully described in Section 12